Position in HLN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,389,031
-$99,215 QoQ
Shares Held
148,878
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#126
of 639 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL SECURITIES, INC. holds $4,721,012 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
24,523 | $1,762,222 | |
| 2 | HLN |
Haleon plc
This page
|
148,878 | $1,389,031 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
910 | $493,065 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
2,887 | $486,574 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,678 | $427,176 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
10,165 | $162,944 |
All Filings in HLN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,389,031 | 148,878 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,488,246 | 148,676 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,361,503 | 134,669 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,066,775 | 118,927 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,296,415 | 125,016 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $811,706 | 78,883 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $752,496 | 78,878 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $570,060 | 53,881 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $376,928 | 45,633 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $283,549 | 33,398 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $176,171 | 21,406 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||